{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T09:08:25Z","timestamp":1789722505940,"version":"4.0.1"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T00:00:00Z","timestamp":1750118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T00:00:00Z","timestamp":1750118400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Non-small cell lung cancer (NSCLC) is highly malignant with limited treatment options, largely due to the inherent tumoral heterogeneity and acquired resistance towards chemotherapy and immunotherapy. RG7388, a known MDM2 inhibitor, exhibited anticancer activity in\n                    <jats:italic>TP53<\/jats:italic>\n                    -wild-type (\n                    <jats:italic>TP53<\/jats:italic>\n                    <jats:sup>WT<\/jats:sup>\n                    ) NSCLC by triggering the p53\/PUMA axis-dependent apoptosis. However, our study uncovered previously unrecognized p53-independent anticancer effects of RG7388 in\n                    <jats:italic>TP53<\/jats:italic>\n                    -mutant (\n                    <jats:italic>TP53<\/jats:italic>\n                    <jats:sup>mutant<\/jats:sup>\n                    ) NSCLC, although the underlying mechanisms remained elusive. Here, we demonstrated that RG7388 specifically induced the NOXA\/caspase-3 axis-dependent apoptosis and gasdermin E (GSDME)-mediated secondary pyroptosis in\n                    <jats:italic>TP53<\/jats:italic>\n                    <jats:sup>mutant<\/jats:sup>\n                    NSCLC, as validated through in silico analyses and multiple biological assays. Mechanically, we identified reactive oxygen species (ROS) as the critical mediator in NOXA upregulation and p38 MAPK pathway activation in RG7388 treated\n                    <jats:italic>TP53<\/jats:italic>\n                    <jats:sup>mutant<\/jats:sup>\n                    NSCLC. This was further supported by the use of ROS scavengers, N-acetylcysteine (NAC), and Ferrostatin-1 (Fer-1), which attenuated these effects. Pharmacologic inhibition of p38 MAPK signaling by SB203580 rescued RG7388-induced ROS-dependent NOXA accumulation and subsequent apoptosis and pyroptosis, highlighting the central role of the ROS\/phosphorylated p38 MAPK (p-p38)\/NOXA\/caspase-3 axis in RG7388-induced\n                    <jats:italic>TP53<\/jats:italic>\n                    <jats:sup>mutant<\/jats:sup>\n                    NSCLC cell death. Our findings revealed a novel mechanism for selectively targeting mutant p53-derived cancer through ROS\/p-p38-mediated NOXA accumulation, offering potential therapeutic implications given the current lack of direct mutant p53 targeting strategies in cancer. Furthermore, immunohistochemical (IHC) analysis of an NSCLC tissue microarray confirmed a strong positive correlation between p-p38 and NOXA expression. Clinical data analysis further suggested that the p-p38\/NOXA axis might be a potential prognostic biomarker for overall survival (OS) in NSCLC patients.\n                  <\/jats:p>","DOI":"10.1038\/s41419-025-07770-2","type":"journal-article","created":{"date-parts":[[2025,6,16]],"date-time":"2025-06-16T20:06:41Z","timestamp":1750104401000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Repurposing MDM2 inhibitor RG7388 for TP53-mutant NSCLC: a p53-independent pyroptotic mechanism via ROS\/p-p38\/NOXA\/caspase-3\/GSDME axis"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6994-1376","authenticated-orcid":false,"given":"Gaoyan","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuelei","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fu","family":"Hui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiqing","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongmin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haifeng","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0202-1211","authenticated-orcid":false,"given":"Xiuming","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8858-0983","authenticated-orcid":false,"given":"Mingzhe","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongli","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenlu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8594-4486","authenticated-orcid":false,"given":"Shuzhen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-8459-416X","authenticated-orcid":false,"given":"Guohua","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7230-7640","authenticated-orcid":false,"given":"Lei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,17]]},"reference":[{"key":"7770_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74:229\u201363.","journal-title":"CA Cancer J Clin"},{"key":"7770_CR2","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1158\/1055-9965.EPI-19-0221","volume":"28","author":"MB Schabath","year":"2019","unstructured":"Schabath MB, Cote ML. Cancer progress and priorities: lung cancer. Cancer Epidemiol Biomark Prev. 2019;28:1563\u201379.","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"7770_CR3","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/S0140-6736(24)01029-8","volume":"404","author":"ML Meyer","year":"2024","unstructured":"Meyer ML, Fitzgerald BG, Paz-Ares L, Cappuzzo F, J\u00e4nne PA, Peters S, et al. New promises and challenges in the treatment of advanced non-small-cell lung cancer. Lancet. 2024;404:803\u201322.","journal-title":"Lancet"},{"key":"7770_CR4","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/s41568-019-0179-8","volume":"19","author":"F Skoulidis","year":"2019","unstructured":"Skoulidis F, Heymach JV. Co-occurring genomic alterations in non-small-cell lung cancer biology and therapy. Nat Rev Cancer. 2019;19:495\u2013509.","journal-title":"Nat Rev Cancer"},{"key":"7770_CR5","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/j.ccell.2024.04.009","volume":"42","author":"Y Liu","year":"2024","unstructured":"Liu Y, Su Z, Tavana O, Gu W. Understanding the complexity of p53 in a new era of tumor suppression. Cancer Cell. 2024;42:946\u201367.","journal-title":"Cancer Cell"},{"key":"7770_CR6","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/s41388-024-03219-6","volume":"44","author":"T Chen","year":"2025","unstructured":"Chen T, Ashwood LM, Kondrashova O, Strasser A, Kelly G, Sutherland KD. Breathing new insights into the role of mutant p53 in lung cancer. Oncogene. 2025;44:115\u201329.","journal-title":"Oncogene"},{"key":"7770_CR7","doi-asserted-by":"crossref","unstructured":"Tian X, Srinivasan PR, Tajiknia V, Sanchez Sevilla Uruchurtu AF, Seyhan AA, Carneiro BA, et al. Targeting apoptotic pathways for cancer therapy. J Clin Invest. 2024;134:e179570.","DOI":"10.1172\/JCI179570"},{"key":"7770_CR8","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.semcancer.2020.07.005","volume":"79","author":"MJ Duffy","year":"2022","unstructured":"Duffy MJ, Synnott NC, O\u2019Grady S, Crown J. Targeting p53 for the treatment of cancer. Semin Cancer Biol. 2022;79:58\u201367.","journal-title":"Semin Cancer Biol"},{"key":"7770_CR9","doi-asserted-by":"publisher","first-page":"5979","DOI":"10.1021\/jm400487c","volume":"56","author":"Q Ding","year":"2013","unstructured":"Ding Q, Zhang Z, Liu JJ, Jiang N, Zhang J, Ross TM, et al. Discovery of RG7388, a potent and selective p53-MDM2 inhibitor in clinical development. J Med Chem. 2013;56:5979\u201383.","journal-title":"J Med Chem"},{"key":"7770_CR10","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1093\/jmcb\/mjz075","volume":"11","author":"G Sanz","year":"2019","unstructured":"Sanz G, Singh M, Peuget S, Selivanova G. Inhibition of p53 inhibitors: progress, challenges and perspectives. J Mol Cell Biol. 2019;11:586\u201399.","journal-title":"J Mol Cell Biol"},{"key":"7770_CR11","doi-asserted-by":"publisher","first-page":"2858","DOI":"10.1038\/s41375-020-0949-z","volume":"34","author":"M Konopleva","year":"2020","unstructured":"Konopleva M, Martinelli G, Daver N, Papayannidis C, Wei A, Higgins B, et al. MDM2 inhibition: an important step forward in cancer therapy. Leukemia. 2020;34:2858\u201374.","journal-title":"Leukemia"},{"key":"7770_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/cddiscovery.2015.26","volume":"1","author":"A Lakoma","year":"2015","unstructured":"Lakoma A, Barbieri E, Agarwal S, Jackson J, Chen Z, Kim Y, et al. The MDM2 small-molecule inhibitor RG7388 leads to potent tumor inhibition in p53 wild-type neuroblastoma. Cell Death Discov. 2015;1:15026.","journal-title":"Cell Death Discov"},{"key":"7770_CR13","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.cell.2023.11.044","volume":"187","author":"K Newton","year":"2024","unstructured":"Newton K, Strasser A, Kayagaki N, Dixit VM. Cell death. Cell. 2024;187:235\u201356.","journal-title":"Cell"},{"key":"7770_CR14","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/s41577-019-0228-2","volume":"20","author":"P Broz","year":"2020","unstructured":"Broz P, Pelegr\u00edn P, Shao F. The gasdermins, a protein family executing cell death and inflammation. Nat Rev Immunol. 2020;20:143\u201357.","journal-title":"Nat Rev Immunol"},{"key":"7770_CR15","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/nature22393","volume":"547","author":"Y Wang","year":"2017","unstructured":"Wang Y, Gao W, Shi X, Ding J, Liu W, He H, et al. Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin. Nature. 2017;547:99\u2013103.","journal-title":"Nature"},{"key":"7770_CR16","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1146\/annurev-immunol-073119-095439","volume":"38","author":"S Kesavardhana","year":"2020","unstructured":"Kesavardhana S, Malireddi RKS, Kanneganti TD. Caspases in cell death, inflammation, and pyroptosis. Annu Rev Immunol. 2020;38:567\u201395.","journal-title":"Annu Rev Immunol"},{"key":"7770_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.855828","volume":"13","author":"XX Liao","year":"2022","unstructured":"Liao XX, Dai YZ, Zhao YZ, Nie K. Gasdermin E: a prospective target for therapy of diseases. Front Pharm. 2022;13:855828.","journal-title":"Front Pharm"},{"key":"7770_CR18","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/s10495-023-01906-5","volume":"29","author":"Q Chen","year":"2024","unstructured":"Chen Q, Sun Y, Wang S, Xu J. New prospects of cancer therapy based on pyroptosis and pyroptosis inducers. Apoptosis. 2024;29:66\u201385.","journal-title":"Apoptosis"},{"key":"7770_CR19","doi-asserted-by":"publisher","first-page":"6066","DOI":"10.1158\/1078-0432.CCR-18-1478","volume":"24","author":"H Lu","year":"2018","unstructured":"Lu H, Zhang S, Wu J, Chen M, Cai MC, Fu Y, et al. Molecular targeted therapies elicit concurrent apoptotic and GSDME-dependent pyroptotic tumor cell death. Clin Cancer Res. 2018;24:6066\u201377.","journal-title":"Clin Cancer Res"},{"key":"7770_CR20","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1007\/s10495-022-01792-3","volume":"28","author":"M Zi","year":"2023","unstructured":"Zi M, Xingyu C, Yang C, Xiaodong S, Shixian L, Shicheng W. Improved antitumor immunity of chemotherapy in OSCC treatment by Gasdermin-E mediated pyroptosis. Apoptosis. 2023;28:348\u201361.","journal-title":"Apoptosis"},{"key":"7770_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1378990","volume":"15","author":"J Wang","year":"2024","unstructured":"Wang J, Wu Z, Zhu M, Zhao Y, Xie J. ROS induced pyroptosis in inflammatory disease and cancer. Front Immunol. 2024;15:1378990.","journal-title":"Front Immunol"},{"key":"7770_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-03454-9","volume":"12","author":"H An","year":"2021","unstructured":"An H, Heo JS, Kim P, Lian Z, Lee S, Park J, et al. Tetraarsenic hexoxide enhances generation of mitochondrial ROS to promote pyroptosis by inducing the activation of caspase-3\/GSDME in triple-negative breast cancer cells. Cell Death Dis. 2021;12:159.","journal-title":"Cell Death Dis"},{"key":"7770_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-06939-5","volume":"15","author":"X An","year":"2024","unstructured":"An X, Yu W, Liu J, Tang D, Yang L, Chen X. Oxidative cell death in cancer: mechanisms and therapeutic opportunities. Cell Death Dis. 2024;15:556.","journal-title":"Cell Death Dis"},{"key":"7770_CR24","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41573-024-00979-4","volume":"23","author":"C Glorieux","year":"2024","unstructured":"Glorieux C, Liu S, Trachootham D, Huang P. Targeting ROS in cancer: rationale and strategies. Nat Rev Drug Discov. 2024;23:583\u2013606.","journal-title":"Nat Rev Drug Discov"},{"key":"7770_CR25","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1158\/0008-5472.CAN-19-1479","volume":"80","author":"J Ommer","year":"2020","unstructured":"Ommer J, Selfe JL, Wachtel M, O\u2019Brien EM, Laubscher D, Roemmele M, et al. Aurora A kinase inhibition destabilizes PAX3-FOXO1 and MYCN and synergizes with navitoclax to induce rhabdomyosarcoma cell death. Cancer Res. 2020;80:832\u201342.","journal-title":"Cancer Res"},{"key":"7770_CR26","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1038\/sj.cdd.4401940","volume":"13","author":"V Labi","year":"2006","unstructured":"Labi V, Erlacher M, Kiessling S, Villunger A. BH3-only proteins in cell death initiation, malignant disease and anticancer therapy. Cell Death Differ. 2006;13:1325\u201338.","journal-title":"Cell Death Differ"},{"key":"7770_CR27","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.canlet.2019.01.011","volume":"447","author":"S Jeong","year":"2019","unstructured":"Jeong S, Yun HK, Jeong YA, Jo MJ, Kang SH, Kim JL, et al. Cannabidiol-induced apoptosis is mediated by activation of Noxa in human colorectal cancer cells. Cancer Lett. 2019;447:12\u201323.","journal-title":"Cancer Lett"},{"key":"7770_CR28","doi-asserted-by":"publisher","first-page":"914","DOI":"10.2174\/1568009618666180308105048","volume":"18","author":"RZ Morsi","year":"2018","unstructured":"Morsi RZ, Hage-Sleiman R, Kobeissy H, Dbaibo G. Noxa: role in cancer pathogenesis and treatment. Curr Cancer Drug Targets. 2018;18:914\u201328.","journal-title":"Curr Cancer Drug Targets"},{"key":"7770_CR29","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1126\/science.288.5468.1053","volume":"288","author":"E Oda","year":"2000","unstructured":"Oda E, Ohki R, Murasawa H, Nemoto J, Shibue T, Yamashita T, et al. Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. Science. 2000;288:1053\u20138.","journal-title":"Science"},{"key":"7770_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-04020-z","volume":"12","author":"S Busche","year":"2021","unstructured":"Busche S, John K, Wandrer F, Vondran FWR, Lehmann U, Wedemeyer H, et al. BH3-only protein expression determines hepatocellular carcinoma response to sorafenib-based treatment. Cell Death Dis. 2021;12:736.","journal-title":"Cell Death Dis"},{"key":"7770_CR31","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1186\/s13046-021-02157-5","volume":"40","author":"PA Townsend","year":"2021","unstructured":"Townsend PA, Kozhevnikova MV, Cexus ONF, Zamyatnin AA Jr, Soond SM. BH3-mimetics: recent developments in cancer therapy. J Exp Clin Cancer Res. 2021;40:355.","journal-title":"J Exp Clin Cancer Res"},{"key":"7770_CR32","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.canlet.2021.11.022","volume":"526","author":"H Choucair","year":"2022","unstructured":"Choucair H, Rahman MK, Umashankar B, Al-Zubaidi Y, Bourget K, Chen Y, et al. The aryl-ureido fatty acid CTU activates endoplasmic reticulum stress and PERK\/NOXA-mediated apoptosis in tumor cells by a dual mitochondrial-targeting mechanism. Cancer Lett. 2022;526:131\u201341.","journal-title":"Cancer Lett"},{"key":"7770_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2020.107588","volume":"31","author":"KK Dijkstra","year":"2020","unstructured":"Dijkstra KK, Monkhorst K, Schipper LJ, Hartemink KJ, Smit EF, Kaing S, et al. Challenges in establishing pure lung cancer organoids limit their utility for personalized medicine. Cell Rep. 2020;31:107588.","journal-title":"Cell Rep"},{"key":"7770_CR34","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1080\/13543776.2021.1860210","volume":"31","author":"X Sun","year":"2021","unstructured":"Sun X, Xu S, Yang Z, Zheng P, Zhu W. Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors for the treatment of non-small cell lung cancer: a patent review (2014-present). Expert Opin Ther Pat. 2021;31:223\u201338.","journal-title":"Expert Opin Ther Pat"},{"key":"7770_CR35","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.882","volume":"12","author":"Q Wang","year":"2022","unstructured":"Wang Q, Li J, Zhu J, Mao J, Duan C, Liang X, et al. Genome-wide CRISPR\/Cas9 screening for therapeutic targets in NSCLC carrying wild-type TP53 and receptor tyrosine kinase genes. Clin Transl Med. 2022;12:e882.","journal-title":"Clin Transl Med"},{"key":"7770_CR36","doi-asserted-by":"crossref","unstructured":"Wang S, Zhao Y, Aguilar A, Bernard D, Yang CY Targeting the MDM2-p53 Protein-Protein Interaction for New Cancer Therapy: Progress and Challenges. Cold Spring Harb Perspect Med. 2017;7:a026245.","DOI":"10.1101\/cshperspect.a026245"},{"key":"7770_CR37","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1038\/40901","volume":"388","author":"QL Deveraux","year":"1997","unstructured":"Deveraux QL, Takahashi R, Salvesen GS, Reed JC. X-linked IAP is a direct inhibitor of cell-death proteases. Nature. 1997;388:300\u20134.","journal-title":"Nature"},{"key":"7770_CR38","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/sj.cdd.4402034","volume":"14","author":"BA Callus","year":"2007","unstructured":"Callus BA, Vaux DL. Caspase inhibitors: viral, cellular and chemical. Cell Death Differ. 2007;14:73\u20138.","journal-title":"Cell Death Differ"},{"key":"7770_CR39","doi-asserted-by":"publisher","first-page":"9384","DOI":"10.1158\/0008-5472.CAN-08-2655","volume":"68","author":"J Lu","year":"2008","unstructured":"Lu J, Bai L, Sun H, Nikolovska-Coleska Z, McEachern D, Qiu S, et al. SM-164: a novel, bivalent Smac mimetic that induces apoptosis and tumor regression by concurrent removal of the blockade of cIAP-1\/2 and XIAP. Cancer Res. 2008;68:9384\u201393.","journal-title":"Cancer Res"},{"key":"7770_CR40","doi-asserted-by":"publisher","first-page":"2544","DOI":"10.1016\/j.molcel.2022.05.014","volume":"82","author":"H Glauninger","year":"2022","unstructured":"Glauninger H, Wong Hickernell CJ, Bard JAM, Drummond DA. Stressful steps: Progress and challenges in understanding stress-induced mRNA condensation and accumulation in stress granules. Mol Cell. 2022;82:2544\u201356.","journal-title":"Mol Cell"},{"key":"7770_CR41","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.cell.2020.03.049","volume":"181","author":"J Guill\u00e9n-Boixet","year":"2020","unstructured":"Guill\u00e9n-Boixet J, Kopach A, Holehouse AS, Wittmann S, Jahnel M, Schl\u00fc\u00dfler R, et al. RNA-induced conformational switching and clustering of G3BP drive stress granule assembly by condensation. Cell. 2020;181:346\u201361.e17.","journal-title":"Cell"},{"key":"7770_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2022.106548","volume":"186","author":"G Jin","year":"2022","unstructured":"Jin G, Zhang Z, Wan J, Wu X, Liu X, Zhang W. G3BP2: Structure and function. Pharmacol Res. 2022;186:106548.","journal-title":"Pharmacol Res"},{"key":"7770_CR43","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2023.189006","volume":"1878","author":"T Li","year":"2023","unstructured":"Li T, Zeng Z, Fan C, Xiong W. Role of stress granules in tumorigenesis and cancer therapy. Biochim Biophys Acta Rev Cancer. 2023;1878:189006.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"7770_CR44","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/onc.2010.441","volume":"30","author":"SH Tonino","year":"2011","unstructured":"Tonino SH, van Laar J, van Oers MH, Wang JY, Eldering E, Kater AP. ROS-mediated upregulation of Noxa overcomes chemoresistance in chronic lymphocytic leukemia. Oncogene. 2011;30:701\u201313.","journal-title":"Oncogene"},{"key":"7770_CR45","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/nrc2694","volume":"9","author":"EF Wagner","year":"2009","unstructured":"Wagner EF, Nebreda AR. Signal integration by JNK and p38 MAPK pathways in cancer development. Nat Rev Cancer. 2009;9:537\u201349.","journal-title":"Nat Rev Cancer"},{"key":"7770_CR46","doi-asserted-by":"publisher","first-page":"6581","DOI":"10.1158\/0008-5472.CAN-09-1161","volume":"69","author":"S Yodkeeree","year":"2009","unstructured":"Yodkeeree S, Sung B, Limtrakul P, Aggarwal BB. Zerumbone enhances TRAIL-induced apoptosis through the induction of death receptors in human colon cancer cells: Evidence for an essential role of reactive oxygen species. Cancer Res. 2009;69:6581\u20139.","journal-title":"Cancer Res"},{"key":"7770_CR47","doi-asserted-by":"publisher","first-page":"4557","DOI":"10.1038\/onc.2008.90","volume":"27","author":"M Hassan","year":"2008","unstructured":"Hassan M, Alaoui A, Feyen O, Mirmohammadsadegh A, Essmann F, Tannapfel A, et al. The BH3-only member Noxa causes apoptosis in melanoma cells by multiple pathways. Oncogene. 2008;27:4557\u201368.","journal-title":"Oncogene"},{"key":"7770_CR48","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1038\/nrc1209","volume":"3","author":"R Eferl","year":"2003","unstructured":"Eferl R, Wagner EF. AP-1: a double-edged sword in tumorigenesis. Nat Rev Cancer. 2003;3:859\u201368.","journal-title":"Nat Rev Cancer"},{"key":"7770_CR49","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.canlet.2013.11.019","volume":"344","author":"X Sui","year":"2014","unstructured":"Sui X, Kong N, Ye L, Han W, Zhou J, Zhang Q, et al. p38 and JNK MAPK pathways control the balance of apoptosis and autophagy in response to chemotherapeutic agents. Cancer Lett. 2014;344:174\u20139.","journal-title":"Cancer Lett"},{"key":"7770_CR50","doi-asserted-by":"publisher","DOI":"10.1016\/j.fct.2022.113046","volume":"164","author":"L Yang","year":"2022","unstructured":"Yang L, Jiang L, Sun X, Li J, Wang N, Liu X, et al. DEHP induces ferroptosis in testes via p38\u03b1-lipid ROS circulation and destroys the BTB integrity. Food Chem Toxicol. 2022;164:113046.","journal-title":"Food Chem Toxicol"},{"key":"7770_CR51","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1016\/j.celrep.2017.10.060","volume":"21","author":"V Debattisti","year":"2017","unstructured":"Debattisti V, Gerencser AA, Saotome M, Das S, Hajn\u00f3czky G. ROS control mitochondrial motility through p38 and the motor adaptor miro\/trak. Cell Rep. 2017;21:1667\u201380.","journal-title":"Cell Rep"},{"key":"7770_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2024.103388","volume":"77","author":"T Hou","year":"2024","unstructured":"Hou T, Zhu L, Zhang Y, Tang Y, Gao Y, Hua S, et al. Lipid peroxidation triggered by the degradation of xCT contributes to gasdermin D-mediated pyroptosis in COPD. Redox Biol. 2024;77:103388.","journal-title":"Redox Biol"},{"key":"7770_CR53","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-024-02130-8","volume":"23","author":"X Zhang","year":"2024","unstructured":"Zhang X, Tang B, Luo J, Yang Y, Weng Q, Fang S, et al. Cuproptosis, ferroptosis and PANoptosis in tumor immune microenvironment remodeling and immunotherapy: culprits or new hope. Mol Cancer. 2024;23:255.","journal-title":"Mol Cancer"},{"key":"7770_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2024.101621","volume":"5","author":"H Yamaguchi","year":"2024","unstructured":"Yamaguchi H, Hsu JM, Sun L, Wang SC, Hung MC. Advances and prospects of biomarkers for immune checkpoint inhibitors. Cell Rep. Med. 2024;5:101621.","journal-title":"Cell Rep. Med"},{"key":"7770_CR55","doi-asserted-by":"publisher","first-page":"9645","DOI":"10.1021\/acs.jmedchem.4c00784","volume":"67","author":"W Liu","year":"2024","unstructured":"Liu W, Ma Y, He Y, Liu Y, Guo Z, He J, et al. Discovery of Novel p53-MDM2 Inhibitor (RG7388)-Conjugated Platinum(IV) Complexes as Potent Antitumor Agents. J Med Chem. 2024;67:9645\u201361.","journal-title":"J Med Chem"},{"key":"7770_CR56","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.molcel.2018.01.023","volume":"69","author":"G Arena","year":"2018","unstructured":"Arena G, Ciss\u00e9 MY, Pyrdziak S, Chatre L, Riscal R, Fuentes M, et al. Mitochondrial MDM2 Regulates Respiratory Complex I Activity Independently of p53. Mol Cell. 2018;69:594\u2013609.e8.","journal-title":"Mol Cell"},{"key":"7770_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2021.106055","volume":"176","author":"A Kabir","year":"2022","unstructured":"Kabir A, Muth A. Polypharmacology: The science of multi-targeting molecules. Pharmacol Res. 2022;176:106055.","journal-title":"Pharmacol Res"},{"key":"7770_CR58","doi-asserted-by":"publisher","first-page":"6771","DOI":"10.1021\/jm200666a","volume":"54","author":"ER Yera","year":"2011","unstructured":"Yera ER, Cleves AE, Jain AN. Chemical structural novelty: on-targets and off-targets. J Med Chem. 2011;54:6771\u201385.","journal-title":"J Med Chem"},{"key":"7770_CR59","doi-asserted-by":"crossref","unstructured":"Lin A, Giuliano CJ, Palladino A, John KM, Abramowicz C, Yuan ML, et al. Off-target toxicity is a common mechanism of action of cancer drugs undergoing clinical trials. Sci Transl Med. 2019;11:eaaw8412.","DOI":"10.1126\/scitranslmed.aaw8412"},{"key":"7770_CR60","doi-asserted-by":"crossref","unstructured":"Zhou F, Guo H, Xia Y, Le X, Tan DSW, Ramalingam SS, et al. The changing treatment landscape of EGFR-mutant non-small-cell lung cancer. Nat Rev Clin Oncol. 2025;22:95\u2013116.","DOI":"10.1038\/s41571-024-00971-2"},{"key":"7770_CR61","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1038\/nrc1506","volume":"4","author":"RS Herbst","year":"2004","unstructured":"Herbst RS, Fukuoka M, Baselga J. Gefitinib-a novel targeted approach to treating cancer. Nat Rev Cancer. 2004;4:956\u201365.","journal-title":"Nat Rev Cancer"},{"key":"7770_CR62","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1038\/nm.3388","volume":"19","author":"CR Chong","year":"2013","unstructured":"Chong CR, J\u00e4nne PA. The quest to overcome resistance to EGFR-targeted therapies in cancer. Nat Med. 2013;19:1389\u2013400.","journal-title":"Nat Med"},{"key":"7770_CR63","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-018-0793-1","volume":"17","author":"Q Liu","year":"2018","unstructured":"Liu Q, Yu S, Zhao W, Qin S, Chu Q, Wu K. EGFR-TKIs resistance via EGFR-independent signaling pathways. Mol Cancer. 2018;17:53.","journal-title":"Mol Cancer"},{"key":"7770_CR64","doi-asserted-by":"crossref","unstructured":"Pellot Ortiz KI, Rechberger JS, Nonnenbroich LF, Daniels DJ, Sarkaria JN MDM2 Inhibition in the Treatment of Glioblastoma: From Concept to Clinical Investigation. Biomedicines. 2023;11:1879.","DOI":"10.3390\/biomedicines11071879"},{"key":"7770_CR65","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1007\/s00204-023-03476-6","volume":"97","author":"B Wang","year":"2023","unstructured":"Wang B, Wang Y, Zhang J, Hu C, Jiang J, Li Y, et al. ROS-induced lipid peroxidation modulates cell death outcome: mechanisms behind apoptosis, autophagy, and ferroptosis. Arch Toxicol. 2023;97:1439\u201351.","journal-title":"Arch Toxicol"},{"key":"7770_CR66","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-41121-z","volume":"14","author":"L Zhang","year":"2023","unstructured":"Zhang L, Song A, Yang QC, Li SJ, Wang S, Wan SC, et al. Integration of AIEgens into covalent organic frameworks for pyroptosis and ferroptosis primed cancer immunotherapy. Nat Commun. 2023;14:5355.","journal-title":"Nat Commun"},{"key":"7770_CR67","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1186\/s13046-018-0909-x","volume":"37","author":"H Yang","year":"2018","unstructured":"Yang H, Villani RM, Wang H, Simpson MJ, Roberts MS, Tang M, et al. The role of cellular reactive oxygen species in cancer chemotherapy. J Exp Clin Cancer Res. 2018;37:266.","journal-title":"J Exp Clin Cancer Res"},{"key":"7770_CR68","doi-asserted-by":"crossref","unstructured":"Luo M, Bao L, Xue Y, Zhu M, Kumar A, Xing C, et al. ZMYND8 protects breast cancer stem cells against oxidative stress and ferroptosis through activation of NRF2. J Clin Invest. 2024;134:e171166.","DOI":"10.1172\/JCI171166"},{"key":"7770_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.216811","volume":"589","author":"S Luo","year":"2024","unstructured":"Luo S, Luo Y, Wang Z, Yin H, Wu Q, Du X, et al. Super-enhancer mediated upregulation of MYEOV suppresses ferroptosis in lung adenocarcinoma. Cancer Lett. 2024;589:216811.","journal-title":"Cancer Lett"},{"key":"7770_CR70","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon SJ, Lemberg KM, Lamprecht MR, Skouta R, Zaitsev EM, Gleason CE, et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell. 2012;149:1060\u201372.","journal-title":"Cell"},{"key":"7770_CR71","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1016\/j.tips.2023.08.012","volume":"44","author":"C Scarpellini","year":"2023","unstructured":"Scarpellini C, Klejborowska G, Lanthier C, Hassannia B, Vanden Berghe T, Augustyns K. Beyond ferrostatin-1: a comprehensive review of ferroptosis inhibitors. Trends Pharm Sci. 2023;44:902\u201316.","journal-title":"Trends Pharm Sci"},{"key":"7770_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2024.103458","volume":"79","author":"E Jog","year":"2024","unstructured":"Jog E, Jainarayanan AK, La Ferlita A, Chakraborty A, Dalwai A, Yahya S, et al. Inhibiting de novo lipogenesis identifies a therapeutic vulnerability in therapy-resistant colorectal cancer. Redox Biol. 2024;79:103458.","journal-title":"Redox Biol"},{"key":"7770_CR73","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.molcel.2023.11.001","volume":"84","author":"F Hecht","year":"2024","unstructured":"Hecht F, Zocchi M, Alimohammadi F, Harris IS. Regulation of antioxidants in cancer. Mol Cell. 2024;84:23\u201333.","journal-title":"Mol Cell"}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07770-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07770-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07770-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T08:03:16Z","timestamp":1750147396000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-025-07770-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,17]]},"references-count":73,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7770"],"URL":"https:\/\/doi.org\/10.1038\/s41419-025-07770-2","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,17]]},"assertion":[{"value":"17 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"452"}}